NCI Starts SBIR Regulatory Help Effort | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute has started a new effort to help firms that have won Phase II funding under its Small Business Innovation Research program to work their way through the regulatory approval process.

The pilot Regulatory Assistance Program, open to new and recent SBIR and Small Business Technology Transfer grantees, will provide up to 30 hours of time with regulatory consultants to companies developing new medical devices or therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.